Week1 Flashcards

1
Q

Weak acid

A

Ampicillin/aspirin
Stomach absorption
Uncharged permeable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Weak base

A

Amiodarone

Intestine absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Bioavailability

A

Efficiency of delivery to systemic circulation
Fraction of dose in systemic circulation in unchanged form
Affected by metabolism & excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

First pass effect

A

Amt of drug eliminated by metabolism before systemic circulation
Determines bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Enteral administration

A

Oral
Rectal
Sublingual
Buccal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Parenteral administration

A
Intravenous
Subcutaneous
Intramuscular
Topical/transdermal 
Pulmonary 
Intrathecal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

IV bioavailability

A

100%

Most rapid onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Phase I reactions

A

Parent drug to polar metabolite
(-OH, -NH2, -SH)
Inc water solubility
Reduction in activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Phase II reactions

A

Polar substances conjugated to endogenous polar substances (glucuronic acid, sulfuric acid, acetic acid, glycine)
Highly polar
Highly water soluble
Completely inactive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Enzyme Induction

A

Repeated substrate administration —> inc isoform metabolite compound —> inc metabolism of isoform substrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CYP2D6 polymorphism

A

Debrisoquin/4-hydroxydebrisoquin ratio
(P-450 substrate)
Low ratio gene duplication (ultrarapid)
High ratio null mutation (poor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Slow acetylators

A

Ar

Slow acetylation of anti-Tb drug isoniazid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CYP2C9

A

Lower affinity for warfarin substrate

Bleeding risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

TPMT*3

A

TPMTL phenotype
Test for allele before starting leukaemia treatment
Use reduced dose in treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Leukocytes

A

Granulocytes:
Neutrophils
Eosinophils
Basophils

Agranulocytes/mononuclear cells:
Lymphocytes
Monocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Azurophilic granules

A
Primary
Produced first in cell differentiation 
Present in all leukocytes
Contents:
Myeloperoxidase 
Cationic proteins
BPI (damages G- bacteria) 
Lysozyme (G+) 
Defensins 
Elastase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Specific granules

A
Secondary
Made later in differentiation
In granulocytes
Contents: 
Lysozyme 
Lactoferrin (competes w bacteria for Fe/Cu) 
Collagenase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

TLRs

A

Toll-like receptors (PRRs)

Bind to PAMPs on pathogens (direct binding)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Fc-are

A
For IgG (opsonin) —> binds to bacteria
Indirect : neutrophil bonds to Fc portion of IgG Ab post-opsonisation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Sterilization

A

All forms of microbial life killed (incl spores)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Disinfection

A

Kill most infections agents on inanimate surfaces

Fail to kill spores, mycobacterium, Hep Virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Sanitation

A

Lower # of bacteria to safe levels

Food industry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Antiseptics

A

Prevent microorganism growth on living tissue

Temporary: recolonisation from pores & ducts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Pasteurization

A

Heat (62C/30mins or 74C/3-5mins) to kill pathogenic bacteria often found in milk (salmonella, mycobacterium, listeria, streptococcus, brucella, campylobacter)
Doesn’t kill spores
Reduce bacterial content by 97-99%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Germicide

A
Kills microorganisms (bacteriocide) 
Sporicides: kill spores
Viricide: viruses 
Fungicide: fungi 
Tuberculocide: mycobacteria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Pyrogens

A

Microbe-derived contaminants that cause fever
Via dead bacteria (LPS)
Low MW, survive filtration and autoclaving
Pyrogen free= never any microbial growth

27
Q

Transformation

A

Free donor DNA (fragment or plasmid) taken you by competent recipient
From later cells, occurs naturally

28
Q

Transfection

A

Donor DNA is bacteriophage

Transformation + infection

29
Q

Transduction

A

Donor DNA carried to recipient in phage capsid

Generalised vs. Specific

30
Q

Conjugation

A

Transfer via conjugation F/R Plasmid
Tra gene
Donor keeps copy (rolling circle replication)

31
Q

Coagulative Necrosis

A

Dead tissue architecture
Enzyme denaturation—> eosinophilic cells no nuclei
WBC phagocytosis
Infarct

32
Q

Liquefactive Necrosis

A

Focal bacterial/fungal infection
Neutrophils and macrophages degrade
CNS hypoxic injury
Pus (dead WBCs/debris)

33
Q

Gangrenous necrosis

A

Loss of blood supply: coagulative necrosis (dry)

+ bacterial infection: liquefactive necrosis (wet)

34
Q

Caseous Necrosis

A

Cheeselike central granuloma
Tuberculosis & infections
Pink, amorphous, granular

35
Q

Fat necrosis

A
Pancreatic lipase release 
Breast trauma 
Fat + calcium = soap (dystrophic calcification) 
Chalky-white 
Normal serum Ca2+
36
Q

Mitochondrial Damage

A
  1. Permeability pore: ox phos fail—> dec ATP
  2. ROS formation
  3. Proteins released (cytochrome c): activate caspases
37
Q

Free radical effects

A

Lipid peroxidation
Oxidative protein modification
DNA lesions

38
Q

Point of no return

A

Inability to reverse mitochondrial dysfunction
No ox phos and dec ATP
Membrane function disturbances

39
Q

Metabolic Derangement Pathways

A
  1. Inadequate removal via packing/transport deficit
  2. Abnormal endogenous substance
  3. Storage diseases
  4. Abnormal exogenous substance
40
Q

Granulocytes

A

Specific granules
Azurophilic granules
Lobulated nucleus

41
Q

Agranulocytes

A

Mononuclear leukocytes
Azurophilic granules
No specific granules
Non-lobulated nucleus

42
Q

Neutrophils in acute inflammation

A

Leukocytosis

Shift to the left

43
Q

Cross-linked IgE basophil activation

A
  1. Degranulation (histamine, heparin sulfate, ECF, NCF)
  2. Cytokines synthesis (IL-4, IL-3)
  3. Membrane phospholipid cleavage (arachadonic acid pathway)
44
Q

Type I Hypersensitivity Response

A

Hay fever
Asthma
Hives
Anaphylaxis

45
Q

Small Lymphocytes

A

6-8 microns
90% of lymphocytes in blood, 70% T cells
Nucleus: RBC size, kidney/round shape, heterochromatic
Sky blue cytoplasm rim

46
Q

Large lymphocytes

A
Via Blast transformation 
30 microns 
Dichromatic nucleus 
Smudged chromatin 
More cytoplasm
47
Q

PAMPs

A
LPS (G-)
Peptidoglycan/lipotechoic acid (G+) 
Unmethylated CpG (bacterial DNA) 
dsRNA (viruses) 
Glycolipids/lipoprotein (bac, fungi, paras)
48
Q

DAMPs

A
Intracellular: 
HSP
HMGB1
S100 
Hyaluronan
Non-protein:
ATP
Uric acid 
Heparin sulfate
DNA
49
Q

PRRs

A
Innate immune system R for PAMPs/DAMPs
Germ line encoded 
Limited repertoire 
On all cells of same lineage 
Cell associated & soluble
50
Q

Resident macrophage

A

Clean up/homeostasis

Kupfer, alveolar, osteoclasts, microfilm, mesangial, sinusoidal

51
Q

Inflammatory macrophage

A
M1 
Blood —> tissue 
Arrive after neutrophils 
Activated by: INF-y, TNF, LPS, microbes 
Inhibited by: IL-13, IL-4, IL-10
Makes: ROS, NO, enzymes (microbicidal); IL-1,12,23, chemokines (inflammation)
52
Q

Alternatively activated macrophages

A
M2 
Downregulate inflammation —> repair 
Makes TGF-B, IL-10 (anti inflammatory) & GFs (tissue repair) 
Not antimicrobial 
Induced by: IL-4, IL-10, IL-13 
Inhibited by: TNF, LPS, microbes, IFN-y
53
Q

IFN-y

A

Type II Interferon
T cells & NK cells
Recruits/activates macrophages
Stimulates adaptive immune response

54
Q

Intrinsic Apoptosis

A
Outer membrane permeability 
Cytochrome C 
BCL2 proteins 
Cell injury: GF withdrawal, DNA damage, protein misfolding 
Activated caspase 9
55
Q

Extrinsic apoptosis

A

TNF-R death domain
Fas (CD95)
FasL on T cells
Fas-FasL: FADD —> binds & activates caspace 8 / 10

56
Q

Labile cells

A

Continuously dividing
GI epithelium, hematopoietic cells
Stem cell pool
Not totipotent

57
Q

Stable cells

A

Quiescent

Kidney, liver, pancreas, SM, lymphocytes

58
Q

Permanent cells

A

Non dividing after injury

Neurons, cardiac m, skeletal

59
Q

Angiogenesis

A
VEGF & NO 
Pericyte detachment 
BM degradation 
Endothelial cell migration & proliferation
Periendothelial cells are recruited 
BM deposited
60
Q

Nutrition & wound healing

A

Protein
Vit C
Copper
T III —> T I collagen (collagenase MMP + Zinc)

61
Q

First intention healing

A

D1 coagulation - fibrin, neutrophils
D2 epithelial cells & BM
D3 macrophages, fibroblasts, nearly thick epidermis
D5 neovascularization peak - granulation tissue
Wk2 fibroblasts & collagen
Mo1 cellular CT scar

62
Q

Second intention healing

A

Large wound, edges not in contact

Myofibroblast wound contraction over 6wks

63
Q

Wound Strength

A

D7 10% strength low collagen
D60-70 100% collagen, 30% strength (TIII)
3mo 100% collagen, 70-80% strength (inc TI)
Never reaches 100%